GTDYX
Price
$39.05
Change
-$0.46 (-1.16%)
Updated
Feb 3 closing price
Net Assets
1.16B
RNWEX
Price
$98.16
Change
+$2.62 (+2.74%)
Updated
Feb 3 closing price
Net Assets
75.46B
Interact to see
Advertisement

GTDYX vs RNWEX

Header iconGTDYX vs RNWEX Comparison
Open Charts GTDYX vs RNWEXBanner chart's image
Invesco Emerging Markets ex-China Y
Price$39.05
Change-$0.46 (-1.16%)
VolumeN/A
Net Assets1.16B
American Funds New World R4
Price$98.16
Change+$2.62 (+2.74%)
VolumeN/A
Net Assets75.46B
GTDYX vs RNWEX Comparison Chart in %
View a ticker or compare two or three
VS
GTDYX vs. RNWEX commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GTDYX is a StrongBuy and RNWEX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNWEX has more cash in the bank: 75.5B vs. GTDYX (1.16B). GTDYX pays higher dividends than RNWEX: GTDYX (3.60) vs RNWEX (1.06). GTDYX was incepted earlier than RNWEX: GTDYX (17 years) vs RNWEX (23 years). GTDYX (1.14) is less costly to investors than RNWEX (0.92). GTDYX is a more actively managed with annual turnover of: 96.00 vs. RNWEX (46.00). RNWEX has a lower initial minimum investment than GTDYX: RNWEX (250) vs GTDYX (1000). RNWEX annual gain was more profitable for investors over the last year : 27.46 vs. GTDYX (24.66). RNWEX return over 5 years is better than : 10.91 vs. GTDYX (-4.84).
GTDYXRNWEXGTDYX / RNWEX
Total Expense Ratio1.140.92124%
Annual Report Gross Expense Ratio1.140.92124%
Fund Existence17 years23 years-
Gain YTD11.8596.073195%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRA250N/A-
Net Assets1.16B75.5B2%
Annual Yield % from dividends3.601.06340%
Returns for 1 year24.6627.4690%
Returns for 3 years23.8442.4456%
Returns for 5 years-4.8410.91-44%
Returns for 10 years91.81123.6674%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GALT3.250.25
+8.33%
Galectin Therapeutics
IEP7.770.03
+0.39%
Icahn Enterprises LP
HUYA4.43N/A
N/A
HUYA
VRAR0.87-0.01
-1.64%
Glimpse Group (The)
MET76.90-2.36
-2.98%
MetLife